Showing results (501-510 of 834) with videos related to

Sort By:
Pageof 84
Diabetes & Vascular Disease Research|May 19, 2016
Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 studyMagnus Thorsten Jensen, Peter Sogaard, Henrik Ullits Andersen, et al.
Cardiovascular Diabetology|February 3, 2026
Echocardiography and inflammatory biomarkers for predicting mortality and major adverse cardiovascular events in type 1 diabetesHashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, et al.
Diabetes Care|October 3, 2022
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)Ian H de Boer, Kamlesh Khunti, Tami Sadusky, et al.
Scandinavian Cardiovascular Journal : SCJ|July 11, 2022
Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetesMads C T Gregers, Morten Schou, Magnus T Jensen, et al.
Nature Reviews. Disease Primers|May 19, 2016
Diabetic kidney diseaseMerlin C Thomas, Michael Brownlee, Katalin Susztak, et al.
Diabetes Research and Clinical Practice|March 5, 2025
Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 studyHashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, et al.
Kidney International|October 6, 2022
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)Ian H de Boer, Kamlesh Khunti, Tami Sadusky, et al.
Cardiovascular Diabetology|October 17, 2020
MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fractionJesper Jensen, Morten Schou, Caroline Kistorp, et al.
Kidney & Blood Pressure Research|April 4, 2023
International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in EuropeStefanie Thöni, Felix Keller, Sara Denicolò, et al.
Journal of Internal Medicine|July 7, 2025
Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetesHashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, et al.
Pageof 84